[来自TCM的多糖体的结构修改及其在输送系统中的应用]
Ying Zeng1, Jin-Ling Duan1, Zhi-Yu Guan1
1School of Pharmacy,Jiangxi University of Chinese Medicine Nanchang 330004,China.
概括
传统中医药 (TCM) 聚糖的结构修改增强了它们用于先进的药物输送系统和自我愈合的水凝的特性. 这些经过修改的多糖提供了更好的药物加载和有针对性的输送能力.
科学领域:
- 生物材料科学 生物材料科学
- 药物运输 药物运输 药物运输
- 传统中国医学 (TCM) 是一种
背景情况:
- 来自传统中医药 (TCM) 的多糖体表现出与其结构密切相关的生物活性.
- 通过结构修改,可以显著提高TCM多糖的物理化学特性.
研究的目的:
- 探索TCM多糖的结构修改,以改善药物输送和水凝应用.
- 调查修改如何影响自我组装到纳米载体和水凝形成.
主要方法:
- 移植修改 (化,乙化,根基移植共聚化,硫化) 调整水友-疏水平衡.
- 交联反应 (Schiff基,离子,共价) 形成水凝.
- 改性多糖的自我组装成纳米载体.
主要成果:
- 修改后的TCM多糖可以形成智能药物递送系统的纳米载体.
- 结构性修改提高了药物加载效率和有针对性的交付.
- 协同交叉连接产生具有优良性能的水凝,适合组织支架.
- 实现了对疏水活性成分的有效封装.
结论:
- 结构修改TCM多糖是一种可行的策略,可以创建先进的药物输送系统和自我愈合的水凝.
- 这些改性多糖体在组织工程和向疗法方面显示出潜力.
- 需要进一步的研究来解决临床翻译的稳定性,免疫反应和质量控制.
相关概念视频
Site-Targeted Drug Delivery Systems: Polymeric Carriers
79
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
79
Modified-Release Drug Delivery Systems: Stimuli-Activated
73
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
73
Modified-Release Drug Delivery Systems: Classification
162
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
162
Modified-Release Drug Delivery Systems: Site-Targeted
70
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
70
Modified-Release Drug Delivery Systems: Rate-Programmed I
76
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
76
Oral Drug Delivery Systems: Introduction
149
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
149


